The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow IPOs

By The Online Investor Staff, updated Fri., May. 27, 11:53 PM

Slide #1. Reata Pharmaceuticals, Inc. Initial Public Offering

Company: Reata Pharmaceuticals, Inc.
Proposed Symbol: RETA
Shares Offered: 5,500,000
Price Per Share: $11.00
Over-Allotment: 825,000
Description: Reata Pharmaceuticals, Inc. ("Reata"), a clinical-stage biopharmaceutical company, today announced the pricing of its initial public offering of 5,500,000 shares of its Class A common stock at $11.00 per share, before underwriting discounts and commissions. Reata has granted the underwriters a 30-day option to purchase up to 825,000 additional shares of its Class A common stock at the initial public offering price. The shares of Class A common stock are expected to begin trading on The NASDAQ Global Market on May 26, 2016, under the ticker symbol "RETA."

IPOs: Reata Pharmaceuticals, Inc.

List of IPOs in this Slideshow:
Company                                 Ticker    IPO Date
The First of Long Island Corporation    FLIC      
Intellia Therapeutics, Inc.             NTLA      
Spring Bank Pharmaceuticals, Inc.       SBPH      
Turning Point Brands, Inc.              TPB       
SiteOne Landscape Supply, Inc.          SITE      
Oncobiologics, Inc.                     ONSIU     
Pulse Biosciences, Inc.                 PLSE      
PhaseRx, Inc.                           PZRX      
Merus B.V.                              MRUS      
Grupo Supervielle S.A.                  SUPV      
Midland States Bancorp, Inc.            MSBI      
Cotiviti Holdings, Inc.                 COTV      
US Foods Holding Corp.                  USFD      
GMS Inc.                                GMS       
Reata Pharmaceuticals, Inc.             RETA      

May 27, 2016    11:53 PM Eastern

IPOs | www.TheOnlineInvestor.com | Copyright © 1998 - 2016, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.